Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Patients with end-stage renal disease undergoing dialysis can develop a secondary carnitine deficiency due to the unrestricted loss of L-carnitine through the dialyser, and L-carnitine has been used for treatment of some patients during long-term haemodialysis
Dosing Protocol A suggested daily titration approach for tolerance assessment
Separate-vial workflow Independent dose control Use separate vials when BPC-157 and TB-500 need different schedules
September 18, 2024
US$ 26.54
US$ 29.95
US$ 20.62
